Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ICAD Inc (NASDAQ:ICAD)

3.89
Delayed Data
As of 11:53am ET
 -0.06 / -1.52%
Today’s Change
2.82
Today|||52-Week Range
6.49
+20.25%
Year-to-Date
SECTOR
Electronic Technology
INDUSTRY
Computer Peripherals
MARKET CAP
$64.7M

Company Description

iCAD, Inc. engages in the provision of advanced image analysis, workflow solutions, and radiation therapy for the early identification and treatment of cancer. It operates through the Cancer Detection and Cancer Therapy segments. The Cancer Detection segment includes image analysis and clinical decision support solutions for mammography, breast tomosynthesis, and computed tomography imaging. The Cancer Therapy segment offers an isotope-free cancer treatment platform technology. The company was founded in 1984 and is headquartered in Nashua, NH.

Contact Information

iCAD, Inc.
98 Spit Brook Road
Nashua New Hampshire 03062
P:(603) 882-5200
Investor Relations:

Employees

Shareholders

Mutual fund holders5.32%
Other institutional25.55%
Individual stakeholders18.90%

Top Executives

Kenneth M. FerryChief Executive Officer & Director
Richard C. ChristopherCFO, Secretary, Treasurer & Executive VP
Jonathan GoSenior Vice President-Research & Development
Kamal C. GogineniChief Commercial Officer-Oncology Solutions & SVP
R. Scott AregladoVice President & Controller